Showing results (1981-1990 of 1,998) with videos related to

Sort By:
Pageof 200
Annals of Surgery|March 22, 2024
Long-term Outcomes following Resection of Adenocarcinoma Arising from Intraductal Papillary Mucinous Neoplasm (A-IPMN) versus Pancreatic Ductal Adenocarcinoma (PDAC): A Propensity-score Matched AnalysisJames Lucocq, James Halle-Smith, Beate Haugk, et al.
Lancet (London, England)|May 22, 2022
Global, regional, and national disease burden estimates of acute lower respiratory infections due to respiratory syncytial virus in children younger than 5 years in 2019: a systematic analysisYou Li, Xin Wang, Dianna M Blau, et al.
United European Gastroenterology Journal|July 29, 2025
The Brescia International Multidisciplinary Consensus Guidelines on the Optimal Pathology Assessment and Multidisciplinary Pathways of Non-Pancreatic Neoplasms in and Around the Ampulla of Vater (PERIPAN)Mohammad Abu Hilal, Bas A Uijterwijk, Daniël H L Lemmers, et al.
Science Translational Medicine|April 7, 2017
Transient tissue priming via ROCK inhibition uncouples pancreatic cancer progression, sensitivity to chemotherapy, and metastasisClaire Vennin, Venessa T Chin, Sean C Warren, et al.
Nature Cancer|August 28, 2023
A first-in-class pan-lysyl oxidase inhibitor impairs stromal remodeling and enhances gemcitabine response and survival in pancreatic cancerJessica L Chitty, Michelle Yam, Lara Perryman, et al.
JAMA Network Open|March 27, 2026
Contemporary Adjuvant Chemotherapy for Intraductal Papillary Mucinous NeoplasmsJames Lucocq, Beate Haugk, Steven White, et al.
Pathology|December 23, 2021
BRAF mutation testing for patients diagnosed with stage III or stage IV melanoma: practical guidance for the Australian settingRichard A Scolyer, Victoria Atkinson, David E Gyorki, et al.
Cancer Discovery|June 9, 2025
Federated Deep Learning Enables Cancer Subtyping by ProteomicsZhaoxiang Cai, Emma L Boys, Zainab Noor, et al.
Science Advances|March 12, 2025
Targeting the NPY/NPY1R signaling axis in mutant p53-dependent pancreatic cancer impairs metastasisCecilia R Chambers, Supitchaya Watakul, Peter Schofield, et al.
Science Advances|July 3, 2024
Temporally resolved proteomics identifies nidogen-2 as a cotarget in pancreatic cancer that modulates fibrosis and therapy responseBrooke A Pereira, Shona Ritchie, Cecilia R Chambers, et al.
Pageof 200